Appelhans Dannielle
- SEC CIK
- 0001874962
No open-market purchases or sales filed in the past year.
Current role at each company
- HALO Halozyme Therapeutics, Inc.Directoras of Sep 2, 2026
- GBIO Generation Bio Co.Directoras of Feb 9, 2026
- RUBY Rubius Therapeutics, Inc.CEO and Presidentas of Feb 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Appelhans Dannielle as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GBIO Generation Bio Co.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2023 (view filing) | Dec 8 | 3 days | Appelhans DannielleDirector | PPurchase | +637 | $1.82 | +$1.16K | +5.3%12.6K after | |
| Dec 11, 2023 (view filing) | Dec 8 | 3 days | Appelhans DannielleDirector | PPurchase | +7.36K | $1.79 | +$13.2K | New position7.36K after | |
| Dec 6, 2023 (view filing) | Dec 4 | 2 days | Appelhans DannielleDirector | PPurchase | +12.0K | $1.50 | +$18.0K | New position12.0K after |
RUBY Rubius Therapeutics, Inc.
CEO and President3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 (view filing)6:08 PM ET | Feb 24 | 3 days | Appelhans DannielleCEO and President | SSale | −10.4K | $0.1274 | −$1.32K | −100.0%0 after | |
| Feb 1, 2023 (view filing)9:40 PM ET | Feb 1 | Same day | Appelhans DannielleCEO and President | SSale | −3.88K | $0.25 | −$969.5 | −27.2%10.4K after | |
| Aug 12, 2022 (view filing) | Aug 10 | 2 days | Appelhans DannielleChief Operating Officer | SSale | −5.74K | $0.80 | −$4.59K | −45.9%6.76K after |